Autoantibodies in pediatric systemic lupus erythematosus: Ethnic grouping, cluster analysis, and clinical correlations

Journal of Rheumatology

Volumn 36, Issue 2, 2009, Pages 416-421

  Jurencák, Roman ^a,b   Fritzler, Marvin ^c   Tyrrell, Pascal ^a,b   Hiraki, Linda ^a,b   Benseler, Susanne ^a,b   Silverman, Earl ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoantibodies; Cluster analysis; Disease associations; Ethnic groups; Pediatrics; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DNA TOPOISOMERASE; DOUBLE STRANDED DNA ANTIBODY; LA ANTIBODY; LUPUS ANTICOAGULANT; RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN ANTIBODY; RIBOSOME PROTEIN; RO ANTIBODY; SM ANTIBODY; DNA; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CAUCASIAN; CHILD; CHROMATIN; CLINICAL FEATURE; CLUSTER ANALYSIS; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNICITY; FEMALE; HUMAN; INFLAMMATION; KIDNEY FAILURE; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEPHRITIS; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; AGE; BLOOD; DISEASE COURSE; ETHNOLOGY; HOSPITALIZATION; IMMUNOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RACE;

ADOLESCENT; AGE FACTORS; AUTOANTIBODIES; CHILD; CLUSTER ANALYSIS; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DISEASE PROGRESSION; DNA; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; SEVERITY OF ILLNESS INDEX; SNRNP CORE PROTEINS;

EID: 64849107507     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080588     Document Type: Article

References (48)

1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
2. ter Borg EJ, Groen H, Horst G, Limburg PC, Wouda AA, Kallenberg CG. Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus. Semin Arthritis Rheum 1990;20:164-173
3. Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988;15:1773-1776 (Pubitemid 19037644)
4. Abuaf N, Johanet C, Chretien P, Absalon BI, Homberg JC, Buri JF. Detection of autoantibodies to Sm antigen in systemic lupus erythematosus by immunodiffusion, ELISA and immunoblotting: variability of incidence related to assays and ethnic origin of patients. Eur J Clin Invest 1990;20:354-359 (Pubitemid 20259834)
5. Field M, Williams DG, Charles P, Maini RN. Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens. Ann Rheum Dis 1988;47:820-825 (Pubitemid 18245346)
6. Tikly M, Burgin S, Mohanlal P, Bellingan A, George J. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol 1996;15:261-265 (Pubitemid 26186503)
7. Isenberg DA, Garton M, Reichlin MW, Reichlin M. Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. Br J Rheumatol 1997;36:229-233 (Pubitemid 27343271)
8. Barron KS, Silverman ED, Gonzales J, Reveille JD. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1993;36:348-354 (Pubitemid 23090602)
9. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990;33:634-643
10. Hoffman IE, Peene I, Meheus L, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004;63:1155-1158 (Pubitemid 39120371)
11. Simmons-O'Brien E, Chen S, Watson R, et al. One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine Baltimore 1995;74:109-130
12. Levy DM, Massicotte MP, Harvey E, Hebert D, Silverman ED. Thromboembolism in paediatric lupus patients. Lupus 2003;12:741-746
13. Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002;29:2531-2536 (Pubitemid 35416957)
14. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005;52:4003-4010
15. Lehman TJ, Hanson V, Singsen BH, Kornreich HK, Bernstein B, King K. The role of antibodies directed against double-stranded DNA in the manifestations of systemic lupus erythematosus in childhood. J Pediatr 1980;96:657-661 (Pubitemid 10110307)
16. Shergy WJ, Kredich DW, Pisetsky DS. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 1988;15:1389-1394 (Pubitemid 18248712)
17. Oshiro AC, Derbes SJ, Stopa AR, Gedalia A. Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus. Ann Rheum Dis 1997;56:272-274 (Pubitemid 27239585)
18. Reichlin M, Broyles TF, Hubscher O, et al. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 1999;42:69-75. (Pubitemid 29042572)
19. Press J, Palayew K, Laxer RM, et al. Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum 1996;39:671-676 (Pubitemid 26119640)
20. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608. (Pubitemid 29171979)
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277 (Pubitemid 13221242)
22. Fritzler MJ. Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 2006;15:422-427 (Pubitemid 44147087)
23. Fritzler MJ. New technologies in the detection of autoantibodies: Evaluation of addressable laser bead immunoassays (ALBIA). In: Conrad K, Chan EK, Fritzler MJ, Humbel R-J, Sack U, Shoenfeld Y, editors. From animal models to human genetics: research on the induction and pathogenicity of autoantibodies. Lengerich, Germany: Pabst Scientific Publishers; 2004:449-462
24. Gussin HA, Ignat GP, Varga J, Teodorescu M. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2001;44:376-383
25. Hopkinson ND, Jenkinson C, Muir KR, Doherty M, Powell RJ. Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis 2000;59:116-119 (Pubitemid 30305608)
26. Alba P, Bento L, Cuadrado MJ, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003;62:556-560 (Pubitemid 36606290)
27. Fernandez M, Alarcon GS, Calvo-Alen J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 2007;57:576-584 (Pubitemid 46764046)
28. Cortes-Hernandez J, Ordi-Ros J, Labrador M, et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 2004;116:165-173 (Pubitemid 38121673)
29. Ghirardello A, Doria A, Zampieri S, et al. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmun 2004;22:235-240 (Pubitemid 38369184)
30. Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology Oxford 2001;40:1405-1412 (Pubitemid 33749032)
31. Stinton LM, Barr SG, Tibbles LA, et al. Autoantibodies in lupus nephritis patients requiring renal transplantation. Lupus 2007;16:394-400. (Pubitemid 47122212)
32. Munves EF, Schur PH. Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum 1983;26:848-853
33. Janwityanuchit S, Verasertniyom O, Vanichapuntu M, Vatanasuk M. Anti-Sm: its predictive value in systemic lupus erythematosus. Clin Rheumatol 1993;12:350-353 (Pubitemid 23306870)
34. Homma M, Mimori T, Takeda Y, et al. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus. J Rheumatol 1987;14 Suppl 13:188-193
35. Thompson D, Juby A, Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1993;2:15-19 (Pubitemid 23115233)
36. Vila LM, Molina MJ, Mayor AM, Peredo RA, Santaella ML, Vila S. Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus. Lupus 2006;15:892-898 (Pubitemid 46044924)
37. Bonfa E, Golombek SJ, Kaufman LD, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317:265-271 (Pubitemid 17100105)
38. Sato T, Uchiumi T, Ozawa T, et al. Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 1991;18:1681-1684
39. Tzioufas AG, Tzortzakis NG, Panou-Pomonis E, et al. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis 2000;59:99-104. (Pubitemid 30305605)
40. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998;41:1819-1827 (Pubitemid 28465536)
41. Schneebaum AB, Singleton JD, West SG, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991;90:54-62.
42. Hanly JG, Urowitz MB, Siannis F, et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 2008;58:843-853
43. Barada FA Jr, Andrews BS, Davis J, Taylor RP. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum 1981;24:1236-1244
44. Beaufils M, Kouki F, Mignon F, Camus JP, Morel-Maroger L, Richet G. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am J Med 1983;74:201-205 (Pubitemid 13192174)
45. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcon GS. Survival impact of autoantibodies in systemic lupus erythematosus. J Rheumatol 1994;21:224-228 (Pubitemid 24078830)
46. Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM. Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM 2000;93:169-174 (Pubitemid 30128704)
47. Toubi E, Khamashta MA, Panarra A, Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995;99:397-401.
48. Asherson RA, Khamashta MA, Gil A, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989;86:391-399 (Pubitemid 19103905)